United States· US:0143-9877_4638263b-1c03-4a32-ba82-70270cf42490
Cefoxitin
A cefoxitin product containing cefoxitin sodium, registered in United States by Hikma Pharmaceuticals USA Inc.. The same ATC class is registered in 7 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Cefoxitin is registered in 7 of 19 countries.
Countries holding a registration under ATC J01DC01 (cefoxitin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 5 of them publish a price we can compare per daily dose
Cefoxitin · ATC J01DC01
7 / 19 countries
- Canada
- Finlandprice
- Franceprice
- Norwayprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cefoxitin costs, country by country.
Normalised to the WHO defined daily dose (6 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cefoxitin · price per daily dose (6 g)
USD · FX 28 Sept 2026
- ES Spain$28.55
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CEFOXITIN SODIUM
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Country
- United States (US)
- ATC code
- J01DC01
- ATC class
- Cefoxitin
- Defined daily dose
- 6 g, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11014398772525 VIAL in 1 CARTON (0143-9877-25) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0143-9877-01)
- ndc110143-9877-25
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
51 interactions on record for cefoxitin.
Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefoxitin · interactions on record
51 records
- 20 moderate
- 2 minor
- 29 info
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- NeomycinA07AA01moderate
- StreptomycinA07AA04moderate
- KanamycinA07AA08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefoxitin in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainCEFOXITINA LDP LABORATORIOS TORLAN 2 G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFGLdp Laboratorios Torlan S.A.
- United KingdomCefoxitin 1g powder for solution for injection vialsSpecial Order
- FranceCEFOXITINE PANPHARMA 1 g, poudre pour solution injectable (IV)PANPHARMA
- CanadaCEFOXITIN FOR INJECTIONTEVA CANADA LIMITED
- FinlandMefoxinMerck Sharp & Dohme B.V.
- NorwayCefoxitin sagentSagent
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Bulgaria · Цефокситин Тенамид
- Estonia · Cefoxitin Auxilia
- Spain · Cefoxitina Ldp-Laboratorios Torlan, Cefoxitina Normon
- France · Cefoxitine Ldp-Laboratorios Torlan, Cefoxitine Panpharma
- United Kingdom (Northern Ireland) · Cefoxitin, Cefoxitin Aft Pharma Uk
- Greece · Mefoxil 2 G/Vial, Μεfoxil
- Italy · Mefoxin
- Portugal · Atralxitina, Cefoxitina Basi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e64c9526-6515-44bc-8dee-cbce49a40300 GET /v1/drugs/e64c9526-6515-44bc-8dee-cbce49a40300?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "2",
"substance": "CEFOXITIN SODIUM",
"productndc": "0143-9877",
"dosage_form": "INJECTION, POWDER, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "g/1",
"application_number": "ANDA065238",
"marketing_category": "ANDA"
}See everything about cefoxitin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.